What you need to know about the HPV Vaccine
Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi
2 views • 7 slides
Pioneering new approaches in cancer care through nursing innovation
Pioneering cancer nurses in Europe are driving advancements in cancer care through innovative approaches, evidence-based knowledge, and personalized patient-centered care. They play a vital role in cancer prevention, healthcare policy enhancement, and education improvement. By putting patients and f
0 views • 12 slides
Understanding Lung Cancer Screening Programs and Criteria
Screening for lung cancer is essential for early detection and intervention. CT scans have shown promise in reducing mortality rates, especially in high-risk populations. While challenges like cost and radiation risk exist, initiatives like the National Lung Screening Trial have demonstrated the eff
4 views • 28 slides
Europe Cancer Diagnostics Market: Emerging Trends in Liquid Biopsy and Next-Gene
The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments
3 views • 4 slides
Dostarlimab 7.5 mg /5 ml: Transforming Cancer Care Landscape in India
Cancer care in India is undergoing a paradigm shift with the introduction of a new immunotherapy treatment: Dostarlimab. This potent formulation (7.5 mg\/5 ml) promises to change the treatment paradigm for oncologists as well as patients fighting cancer. Dostarlimab 7.5 mg\/5 ml is a revolutionary i
5 views • 7 slides
Advances in Perioperative Treatment of Lung Cancer: A Comprehensive Review
Explore the evolution of perioperative treatment for lung cancer from historical perspectives to current advancements. Learn about the efficacy of different chemotherapy agents, immunotherapies, and adjuvant treatments, along with the impact on patient outcomes and resectability criteria. Discover t
0 views • 19 slides
Latest Research and Studies on Lung Cancer - Update May 2024
This research update includes information on national recruitment to lung cancer studies, comparison of national vs. regional recruitment, and detailed descriptions of various studies and trials related to lung cancer. The studies cover areas such as treatment advancements, observational studies, ma
2 views • 13 slides
Cancer Therapy Evaluation Program (CTEP) Overview
The Cancer Therapy Evaluation Program (CTEP) aims to enhance cancer patients' lives by advancing cancer treatment through research and clinical trials. The Program includes a Protocol and Information Office (PIO) to streamline trial development processes. It funds national cancer research and focuse
0 views • 27 slides
National Optimal Lung Cancer Pathway: Referral to Treatment Update 2020 Version 3.0
This optimal pathway aims to improve outcomes in lung cancer by reducing delays in diagnosis, staging, and treatment, while meeting waiting time targets. It emphasizes remote triage, test bundles, and efficient clinic use. The pathway includes maximum waiting times, timely treatment pathways, and gu
0 views • 16 slides
Southampton Lung Health Check Programme Overview
Southampton is part of a national Lung Health Check programme offering free lung MOT tests to smokers and former smokers aged 55-74. Specially trained nurses conduct checks in mobile vans around the city, aiming to detect lung problems early. Eligible individuals will receive invitation letters from
0 views • 10 slides
Transforming Lung Cancer Care in South West: Cancer Alliance Priorities
Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag
0 views • 23 slides
Molecularly-Guided Therapy vs Platinum Chemotherapy in CUP Patients
This trial aims to compare the efficacy and safety of molecularly-guided therapy or cancer immunotherapy based on genomic profiling with platinum-based chemotherapy in patients with cancer of unknown primary site. The study design includes multiple treatment regimens guided by genomic profiles, with
4 views • 9 slides
Radiology-Pathology Correlation Case Presentation: Ms. DR - Lung Mass Evaluation
Ms. DR, a 62-year-old female with a history of tobacco use, presents with a right lung mass and possible metastatic disease. Imaging reveals a FDG-avid lung mass suspicious for primary malignancy. After obtaining informed consent, a CT-guided core biopsy is performed, showing cohesive, medium-sized
1 views • 16 slides
Cancer Survival Rates in Europe: Trends and Disparities
Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w
0 views • 17 slides
Rapid Investigation Service Overview
The Wessex RIS is a new cancer referral pathway aimed at patients with concerning non-specific symptoms. Working in partnership with acute trusts in Wessex, the service provides timely investigations to exclude cancer in such patients. Established as part of the National Rapid Diagnostic Centre proj
0 views • 15 slides
Understanding Data Submission in Cancer Registry Systems
Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p
1 views • 11 slides
Advances in Anticoagulation Therapy for Cancer-Related VTE and Stroke
Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an
3 views • 9 slides
Breakthrough Cancer Therapy in India: Selpercatinib 40 80 mg for RET Mutations
Selpercatinib 40 & 80 mg is an innovative targeted therapy designed to inhibit RET gene mutations, providing a highly precise treatment option for patients with non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and RET fusion-positive thyroid cancers. Now available as Selpercatinib
0 views • 11 slides
Addressing Lung Cancer Risk in Renters: Strategies for Radon Reduction
Lung cancer risk in renters due to radon exposure is a significant concern, especially for those in lower-income brackets. This article sheds light on the synergistic risks of radon and tobacco smoke, emphasizing the importance of reducing radon levels in rental properties to safeguard the health of
0 views • 24 slides
Developing the Prehab Pathway for Lung Cancer Patients by Dr. Louise Brown
Dr. Louise Brown from North Manchester General Hospital leads the development of a prehab pathway for lung cancer patients in the NE sector. The project aims to enhance patient outcomes through pre-surgical preparation, addressing challenges such as frailty, deprivation, and lack of access to assess
0 views • 14 slides
Humber, Coast and Vale Cancer Alliance - Cancer Champions Programme Overview
The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in
0 views • 10 slides
Lung Cancer Questions and Answers
This set of questions covers various aspects of lung cancer, including statistics, TNM staging, non-small cell lung cancers, and small cell lung cancers. Each question presents multiple choices, testing the reader's knowledge on different topics related to lung cancer.
0 views • 9 slides
Patient Mobility and Cancer: Role of Joint Actions in European Cancer Care
Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e
0 views • 7 slides
Comprehensive IGRT Lung Module for Radiation Therapy Education
Improve your understanding of Image-Guided Radiation Therapy (IGRT) with this comprehensive lung module. Discover the importance of accurate targeting for lung cancer treatment, learn about cross-sectional anatomy, explore regions of interest, and understand machine parameters for Varian and Elekta
0 views • 32 slides
National Cancer Patient Experience Survey 2021 Results Overview
National Cancer Patient Experience Survey (NCPES) for 2021 focused on brain tumour patients and was led by Lisa Wilks, the Lead Cancer Nurse at NBT. The survey, commissioned by NHS England, aimed to monitor cancer care progress, drive quality improvements, and inform stakeholders. Methodology includ
0 views • 26 slides
Improvements in Outcomes for Patients with Early Breast Cancer Over the Past 20 Years
Presenter Carolyn Taylor and team present data on improvements in outcomes for women with early breast cancer from 1993 to 2015 in England. The study highlights patient and tumor factors, breast cancer mortality rates, long-term follow-up data, and the need for big data analysis. The research focuse
0 views • 18 slides
Debunking Common Myths About Cancer and Nutrition
The journey of cancer diagnosis brings forth various challenges, including misconceptions about nutrition. Debunking myths like soy stimulating cancer cells, sugar feeding cancer, and acidic diets curing cancer is crucial for informed decision-making. Evidence shows that soy can be a part of a healt
1 views • 11 slides
Overview of Respiratory System Components and Functions
The respiratory system consists of vital components like pulmonary compliance and surfactant, crucial for proper lung function. Pulmonary compliance reflects the lung's ease of expansion, influenced by factors like lung elasticity and surface tension. Surfactant, produced by type II alveolar cells,
0 views • 15 slides
Comprehensive Update on Lung Cancer Diagnosis and Management According to 2019 NICE Guidelines
Providing a detailed overview of the 2019 NICE guidance on lung cancer, this content covers various aspects including the role of NICE, types of guidance provided, updates on lung cancer surgery, recommendations on tobacco addiction interventions, diagnostic approaches, and new protocols for brain i
0 views • 35 slides
Global Cancer Statistics and Trends
The data presented showcases global cancer statistics from various years, highlighting the prevalence of different types of cancer across genders. It includes information on the estimated number of cancer cases, common types of cancers, and trends expected up to 2035. Lung cancer, breast cancer, and
0 views • 83 slides
Targeted Treatment Options for Lung Cancer Patients
Explore targeted treatment approaches for lung cancer through real-life patient cases, expert insights, and updates on therapies. Learn about personalized care, innovative options, and advancements in non-small cell lung cancer treatment. Delve into disclosures from healthcare professionals involved
0 views • 49 slides
Inhibition of TNKS for Lung Cancer Growth Reduction
This study proposes inhibiting TNKS1 and TNKS2 as a potential strategy to reduce lung cancer proliferation. The research explores the impact of pharmacological or genetic inhibition of TNKS on lung cancer growth. It emphasizes the need for new approaches in treating or preventing lung cancer. The fi
0 views • 16 slides
Integration of Complementary Medicine in Cancer Care in Tuscany
Describes the successful integration of Complementary Medicine in the network of Cancer Departments within the Tuscan Public Healthcare System. The initiative, spearheaded by experts in both Complementary Medicine and medical oncology, has led to the development of Regional Guidelines incorporating
0 views • 4 slides
Kentucky Cancer Registry - COVID-19 Impact on Cancer Patients
The Kentucky Cancer Registry addresses the impact of COVID-19 on cancer patients, highlighting increased risks, altered treatment plans, and the importance of adjusting therapies to reduce infection rates. The registry emphasizes the higher incidence of COVID-19 in cancer patients compared to the ge
1 views • 58 slides
Utility of Lung Ultrasonography in Pediatric Pneumonia Diagnosis
Pneumonia, a leading cause of pediatric mortality globally, presents diagnostic challenges as history and physical exams may not reliably differentiate viral lung infections from bacterial pneumonia. This study explores the feasibility and safety of substituting lung ultrasonography (LUS) for chest
0 views • 21 slides
Understanding Cancer Survival Statistics in England
Cancer survival statistics in England, analyzed in collaboration between Public Health England (PHE) and the Office for National Statistics (ONS), provide crucial insights into the effectiveness of cancer services. These statistics measure the mortality rates of cancer patients and inform various st
0 views • 25 slides
Insights into Lung Transplantation: Causes of Death and Survival Rates
Explore the common causes of death in lung transplant recipients, including malignancy, graft failure, and infections. Understand the relative incidence of leading causes of death in adult lung transplant recipients over different time periods. Learn about survival rates following lung transplantati
0 views • 40 slides
Cancer Types Spending in Europe
Learn about the spending on various types of cancer in Europe including breast cancer, colorectal cancer, prostate cancer, lung cancer, ovary cancer, and pancreatic cancer. The information is based on the Comparator Report on Cancer in Europe 2019, which covers disease burden, costs, and access to m
1 views • 7 slides
Clinical Investigator Perspectives on Lung Cancer Management: Live CME Event
Clinical investigators including D. Ross Camidge, Stephen V. Liu, Solange Peters, Gregory J. Riely, and David R. Spigel share their insights on lung cancer management at a live CME event in Chicago. The moderator, Neil Love, discloses ties with various commercial interests for educational grants. Th
0 views • 9 slides
Lung Cancer Education Event - Greater Manchester 2023
The Lung Cancer Education Event in Greater Manchester on February 1, 2023, is designed for all healthcare professionals involved in lung cancer care. The agenda includes sessions on optimizing outcomes post-Covid-19, evolving treatments, essential updates in lung cancer, and thoracic oncology. Join
1 views • 4 slides